Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome
-
Published:2019-09-25
Issue:10
Volume:121
Page:869-876
-
ISSN:0007-0920
-
Container-title:British Journal of Cancer
-
language:en
-
Short-container-title:Br J Cancer
Author:
Dashti S. Ghazaleh, Li Wing Yan, Buchanan Daniel D.ORCID, Clendenning Mark, Rosty Christophe, Winship Ingrid M., Macrae Finlay A., Giles Graham G., Hardikar Sheetal, Hua Xinwei, Thibodeau Stephen N., Figueiredo Jane C., Casey Graham, Haile Robert W., Gallinger Steven, Le Marchand Loïc, Newcomb Polly A., Potter John D., Lindor Noralane M., Hopper John L., Jenkins Mark A., Win Aung KoORCID
Abstract
Abstract
Background
Type 2 diabetes mellitus and high total cholesterol and triglycerides are known to be associated with increased colorectal cancer risk for the general population. These associations are unknown for people with a germline DNA mismatch repair gene mutation (Lynch syndrome), who are at high risk of colorectal cancer.
Methods
This study included 2023 (56.4% female) carriers with a mismatch repair gene mutation (737 in MLH1, 928 in MSH2, 230 in MSH6, 106 in PMS2, 22 in EPCAM) recruited by the Colon Cancer Family Registry between 1998 and 2012. Weighted Cox regression was used to estimate the hazard ratios (HR) and 95% confidence intervals (CI) for the associations between self-reported type 2 diabetes, high cholesterol, triglyceride and colorectal cancer risk.
Results
Overall, 802 carriers were diagnosed with colorectal cancer at a median age of 42 years. A higher risk of colorectal cancer was observed in those with self-reported type-2 diabetes (HR 1.92; 95% CI, 1.03–3.58) and high cholesterol (HR 1.76; CI 1.23–2.52) compared with those without these conditions. There was no evidence of high triglyceride being associated with colorectal cancer risk.
Conclusion
For people with Lynch syndrome, self-reported type-2 diabetes mellitus and high cholesterol were associated with increased colorectal cancer risk.
Funder
Department of Health | National Health and Medical Research Council U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference44 articles.
1. Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K. et al. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer. Nature. 368, 258–261 (1994). 2. Nicolaides, N. C., Papadopoulos, N., Liu, B., Weit, Y.-F., Carter, K. C., Ruben, S. M. et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 371, 75–80 (1994). 3. Fishel, R., Lescoe, M., Rao, M., Copeland, N., Jenkins, N., Garber, J. et al. The human mutator gene homolog MSH2 and its associations with hereditary nonpolyposis colon cancer. Cell. 75, 1027–1038 (1993). 4. Akiyama, Y., Sato, H., Yamada, T., Nagasaki, H., Tsuchiya, A., Abe, R. et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 57, 3920–3923 (1997). 5. Ligtenberg, M. J., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M. et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nature Genet. 41, 112–117 (2009).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|